Categories: aggregated

Pharmaceutical Companies Win Big with Schedule 3 Classification of Cannabis – Desheduling is the Only Way for True Equity

For decades, Joe Biden has been cozy with Big Pharma, accepting millions in campaign contributions from drug companies over his long political career. It’s no secret that the pharmaceutical industry vehemently opposes cannabis legalization, as legal weed represents a major threat to their profits from opiate painkillers and other drugs. Pharma much prefers that cannabis remain illegal, or barring that, placed into a restrictive category like Schedule III that they can control and corner the market on.

Jason

Share
Published by
Jason

Recent Posts

ILGM’s Home Grow Tour 2025

ILGM is hitting the road in their revamped Airstream Bambi for the Home Grow Tour…

1 day ago

Buddha Chief raises vibrations at new Housing Works dispensary in NoMad

Meet the music and cannabis pioneer behind the Upper East Side's hottest new dispensary. The…

2 days ago

The Rise and Fall of the Cannabis Industry – Is There Any Hope Under Trump 2.0?

Let's dive into how this iconic marijuana mecca rose to prominence, flourished during the golden…

2 days ago

Leafly’s top 3 THCA vape carts of 2025

Find the best THCA vape carts of 2025. We reviewed popular THCA carts & chose…

3 days ago

LA’s hype weed contest Zalympix 2025 winners and where to buy them

Los Angeles’ top contest picks some bangers The post LA’s hype weed contest Zalympix 2025…

3 days ago

America is Rethinking Marijuana Legalization – A Response to the National Review

Today, I'm going to examine these claims with a critical eye. While I agree that…

5 days ago